Brokerages expect UnitedHealth Group Inc (NYSE:UNH) to report $54.92 billion in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for UnitedHealth Group’s earnings. The lowest sales estimate is $54.54 billion and the highest is $55.15 billion. UnitedHealth Group reported sales of $48.72 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 12.7%. The business is expected to announce its next earnings report on Tuesday, April 17th.
On average, analysts expect that UnitedHealth Group will report full year sales of $54.92 billion for the current fiscal year, with estimates ranging from $222.59 billion to $225.72 billion. For the next year, analysts expect that the firm will report sales of $241.42 billion per share, with estimates ranging from $236.09 billion to $244.40 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the business posted $2.11 EPS.
UNH has been the topic of several recent analyst reports. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $239.70.
In related news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by insiders.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Capital International Investors grew its holdings in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after acquiring an additional 3,304,902 shares in the last quarter. Jennison Associates LLC grew its holdings in UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC grew its holdings in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC grew its holdings in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares in the last quarter. 86.09% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group (NYSE UNH) opened at $238.43 on Thursday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $230,530.00, a PE ratio of 22.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. UnitedHealth Group has a fifty-two week low of $156.09 and a fifty-two week high of $238.96.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Expected to Announce Quarterly Sales of $54.92 Billion” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/18/unitedhealth-group-inc-unh-expected-to-announce-quarterly-sales-of-54-92-billion.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Get a free copy of the Zacks research report on UnitedHealth Group (UNH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.